(Q34688940)

4 August 2017

Oral acyclovir in the treatment of acute herpes zoster ophthalmicus. (English)

1 reference

4 August 2017

1 reference

1 reference

Cobo LM

1

1 reference

4 August 2017

Foulks GN

2

1 reference

4 August 2017

Liesegang T

3

1 reference

4 August 2017

Lass J

4

1 reference

4 August 2017

Sutphin JE

5

1 reference

4 August 2017

Wilhelmus K

6

1 reference

4 August 2017

Jones DB

7

1 reference

4 August 2017

Chapman S

8

1 reference

4 August 2017

Segreti AC

9

1 reference

4 August 2017

King DH

10

1 reference

4 August 2017

1 June 1986

1 reference

4 August 2017

1 reference

4 August 2017

93

1 reference

4 August 2017

763-770

1 reference

4 August 2017

6

1 reference

Population-based study of herpes zoster and its sequelae

4 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2886%2933678-9

7 January 2021

Complications of herpes zoster ophthalmicus

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2886%2933678-9

7 January 2021

Histopathology of Herpes Zoster Ophthalmicus

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2886%2933678-9

7 January 2021

The progression of the ocular abnormalities of herpes zoster. Histopathologic observations of nine cases

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2886%2933678-9

7 January 2021

In vitro susceptibility of varicella-zoster virus to acyclovir

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2886%2933678-9

7 January 2021

Pharmacokinetics of acyclovir after intravenous and oral administration.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2886%2933678-9

7 January 2021

Oral acyclovir in the therapy of acute herpes zoster ophthalmicus. An interim report

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2886%2933678-9

7 January 2021

Effect of low dose acyclovir (5 mg/kg) on virus shedding, interferon and humoral immunity in herpes zoster

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2886%2933678-9

7 January 2021

The incidence of herpes zoster in patients with Hodgkin's disease. An analysis of prognostic factors

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2886%2933678-9

7 January 2021

Herpes zoster dendritic keratitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2886%2933678-9

7 January 2021

Oral acyclovir for herpes zoster

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2886%2933678-9

7 January 2021

10.1016/S0161-6420(86)33678-9

Identifiers

DOI

0 references

1 reference